fda stop compounding semaglutide news FDA moves to compounding GLP-1 drugs FDA restricts non-approved compounded GLP-1

Ali emphasized that this is not a direct side effect of the medication itself, but a physiological change that can occur with any significant weight loss

The clinical trial data backs this up

Build a Consistent Eating Routine Instead of skipping meals entirely, plan small portions of nutrient-dense foods every few hours

we confirm a GLP-1 program is right for you and pick your starting medication

Lancet 373, 473481

Mendelsohn noted that the agreement with Novo is not a licensing deal, but said it's a "good validation for where we are and where this product could ultimately end up." For now, doctors say several important questions remain unanswered, but also acknowledge the potential of the treatment